These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24796111)

  • 1. [Recent progress and prospects for research on urate efflux transporter ABCG2].
    Ichida K
    Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased extra-renal urate excretion is a common cause of hyperuricemia.
    Ichida K; Matsuo H; Takada T; Nakayama A; Murakami K; Shimizu T; Yamanashi Y; Kasuga H; Nakashima H; Nakamura T; Takada Y; Kawamura Y; Inoue H; Okada C; Utsumi Y; Ikebuchi Y; Ito K; Nakamura M; Shinohara Y; Hosoyamada M; Sakurai Y; Shinomiya N; Hosoya T; Suzuki H
    Nat Commun; 2012 Apr; 3():764. PubMed ID: 22473008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Ikebuchi Y; Ito K; Kusanagi Y; Chiba T; Tadokoro S; Takada Y; Oikawa Y; Inoue H; Suzuki K; Okada R; Nishiyama J; Domoto H; Watanabe S; Fujita M; Morimoto Y; Naito M; Nishio K; Hishida A; Wakai K; Asai Y; Niwa K; Kamakura K; Nonoyama S; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Hamajima N; Shinomiya N
    Sci Transl Med; 2009 Nov; 1(5):5ra11. PubMed ID: 20368174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.
    Matsuo H; Nakayama A; Sakiyama M; Chiba T; Shimizu S; Kawamura Y; Nakashima H; Nakamura T; Takada Y; Oikawa Y; Takada T; Nakaoka H; Abe J; Inoue H; Wakai K; Kawai S; Guang Y; Nakagawa H; Ito T; Niwa K; Yamamoto K; Sakurai Y; Suzuki H; Hosoya T; Ichida K; Shimizu T; Shinomiya N
    Sci Rep; 2014 Jan; 4():3755. PubMed ID: 24441388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
    Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
    Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
    Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
    Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
    Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
    Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
    Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.
    Takada T; Ichida K; Matsuo H; Nakayama A; Murakami K; Yamanashi Y; Kasuga H; Shinomiya N; Suzuki H
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):275-81. PubMed ID: 24940679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
    Ohashi Y; Toyoda M; Saito N; Koizumi M; Kanai G; Komaba H; Kimura M; Wada T; Takahashi H; Takahashi Y; Ishida N; Kakuta T; Fukagawa M; Ichida K
    Sci Rep; 2023 Jan; 13(1):93. PubMed ID: 36639673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2: the molecular mechanisms of urate secretion and gout.
    Woodward OM
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F485-8. PubMed ID: 26136557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.